The relentless cycle of flare-ups for those with severe Chronic Obstructive Pulmonary Disease has long demanded a more precise therapeutic weapon, a need the UK's health authorities have now addressed with a new approval. This review evaluates Nucala (mepolizumab), recently authorized by the MHRA
With the recent FDA approval of Novo Nordisk's oral version of Wegovy, the landscape of weight management treatment is poised for a monumental shift. We sat down with biopharma expert Ivan Kairatov, whose extensive background in research and development offers a unique lens on this
In the years following the Supreme Court’s landmark 2022 Dobbs decision that overturned federal abortion rights, a striking and counterintuitive trend has emerged across the United States. While numerous states moved swiftly to enact severe restrictions or outright bans on the procedure, the total
For the first time in more than a decade, the therapeutic landscape for newly diagnosed metastatic HER2-positive breast cancer has been fundamentally altered by a landmark U.S. Food and Drug Administration decision. The agency has officially approved a combination therapy featuring Enhertu and
For individuals born with the rare and debilitating genetic disorder Wiskott-Aldrich syndrome, the hope for a cure has long been shadowed by the immense challenge of finding a perfectly matched stem cell donor. This condition, which severely compromises the immune system and blood clotting, leaves
I'm Ivan Kairatov, and my work takes me deep into a world most people never see, yet it's critical to all of us: the microbial ecosystem inside our wastewater treatment plants. For decades, we've thought of these facilities as simple filters, removing pollutants and a few known bacteria. But our